A large Israeli study confirms that, among patients with ovarian cancer, carrying the BRCA1/2 mutation confers a survival advantage. Medscape Medical News
ESAs are no longer indicated for use in cancer patients for chemotherapy-induced anemia if the intent of chemotherapy is to cure the patient. Medscape Medical News
Long-term air pollution exposure is related to certain cancer deaths in recent studies. In this full cohort using another exposure assessment, are traffic-related air pollution and mortality related? Environmental Health Perspectives
Is there a new role for EGFR inhibitors in the treatment of lung cancer? In this expert column, Dr. Neil and Dr. Heist review the latest data. Medscape Hematology-Oncology
Everolimus, an investigational mTor inhibitor, improved survival in patients with metastatic renal cell carcinoma whose disease had progressed after treatment with sunitinib and/or sorafenib. Medscape Medical News
